{{Rsnum
|rsid=376618
|Gene=FGFR4
|Chromosome=5
|position=177090796
|Orientation=minus
|GMAF=0.185
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FGFR4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 55.4 | 39.3 | 5.4
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 44.2 | 46.3 | 9.5
| ASW | 47.4 | 40.4 | 12.3
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 74.3 | 24.8 | 1.0
| LWK | 51.8 | 42.7 | 5.5
| MEX | 69.0 | 31.0 | 0.0
| MKK | 53.8 | 40.4 | 5.8
| TSI | 42.2 | 51.0 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21656577
|Title=Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma
}}

{{PMID Auto
|PMID=18762813
|Title=Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.
|OA=1
}}

{{PMID Auto
|PMID=19500394
|Title=Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.
|OA=1
}}

{{GET Evidence
|gene=FGFR4
|aa_change=Pro136Leu
|aa_change_short=P136L
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs376618
|overall_frequency_n=7767
|overall_frequency_d=10758
|overall_frequency=0.721974
|n_genomes=55
|n_genomes_annotated=0
|n_haplomes=93
|n_articles=0
|n_articles_annotated=0
|nblosum100=7
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}